V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220177 | 20083865 | 1.69 | 77.2 | null | 2015-05-30 | 2015-05-30 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100116607 |
| 20220179 | 20083866 | 1.71 | 69.7 | null | 2017-10-30 | 2017-10-31 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101150997 |
| 20220181 | 20083867 | 1.7 | 82.4 | null | 2019-10-30 | 2019-10-30 | Enzalutamide | 02 | null | CETUXIMAB | 100830876 |
| 20220182 | 20083868 | 1.6 | 48.5 | Palliative (P) | 2018-07-17 | 2018-08-01 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101373007 |
| 20220187 | 20083869 | null | 55.3 | null | 2017-02-03 | 2017-03-01 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100866656 |
| 20220190 | 20083870 | 0 | 75.6 | Neo-adjuvant (N) | 2018-07-19 | 2018-07-19 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101593070 |
| 20220192 | 20083871 | 1.83 | 51.4 | Neo-adjuvant (N) | 2019-12-08 | 2019-12-15 | Enzalutamide | 02 | Y | CETUXIMAB | 101264321 |
| 20220193 | 20083872 | 1.53 | 126.2 | Palliative (P) | 2018-05-14 | 2018-05-27 | Enzalutamide | N | N | CARBOPLATIN + GEMCITABINE | 100891705 |
| 20220196 | 20083873 | 1.58 | 92 | null | 2017-04-25 | 2017-04-29 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101756051 |
| 20220199 | 20083874 | 0 | 0 | Neo-adjuvant (N) | 2019-09-12 | 2019-09-12 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 2 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100384048 |
| 20220201 | 20083875 | 1.55 | 0 | null | 2021-04-28 | 2021-04-28 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100624972 |
| 20220202 | 20083876 | 0 | 0 | Palliative (P) | 2019-09-26 | 2019-10-11 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100760534 |
| 20220205 | 20083877 | 1.6 | 61.8 | Palliative (P) | 2016-06-04 | 2016-06-13 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100354776 |
| 20220206 | 20083878 | 1.8 | 65.9 | Palliative (P) | 2019-05-28 | 2019-06-01 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101748309 |
| 20220207 | 20083879 | 1.74 | 112 | Palliative (P) | 2019-01-26 | 2019-01-26 | Capecitabine + Cisplatin + RT | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100870888 |
| 20220210 | 20083880 | 1.7 | 103.2 | Palliative (P) | 2019-04-08 | 2019-04-08 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101175259 |
| 20220212 | 20083881 | 1.69 | 98.8 | Palliative (P) | 2020-03-12 | 2020-03-13 | Enzalutamide | 02 | N | ECF | 101622615 |
| 20220222 | 20083882 | 1.66 | 79 | Palliative (P) | 2019-08-09 | 2019-08-09 | ECF | 02 | N | CETUXIMAB | 101680995 |
| 20220227 | 20083883 | 1.72 | 47.1 | Palliative (P) | 2017-03-15 | 2017-03-15 | Enzalutamide | N | N | ATEZOLIZUMAB + BEVACIZUMAB | 101637500 |
| 20220228 | 20083884 | 1.6 | 78.55 | Curative (C) | 2017-02-09 | 2017-02-24 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 100478917 |
| 20220230 | 20083885 | 1.75 | 105 | Palliative (P) | null | 2017-12-22 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101830078 |
| 20220231 | 20083886 | 1.56 | 92.3 | null | 2017-05-15 | 2017-05-22 | Enzalutamide | 02 | null | OCTREOTIDE | 100709636 |
| 20220236 | 20083887 | 1.63 | null | Neo-adjuvant (N) | 2021-09-12 | 2021-09-12 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100323153 |
| 20220237 | 20083888 | 1.61 | 51 | Palliative (P) | 2019-03-24 | 2019-03-24 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100670328 |
| 20220238 | 20083889 | 1.93 | 63 | Curative (C) | null | 2016-02-25 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100564562 |
| 20220240 | 20083890 | null | null | null | 2019-11-10 | 2019-11-18 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 100119118 |
| 20220241 | 20083891 | 1.79 | 63.7 | Palliative (P) | 2017-10-15 | 2017-10-16 | Enzalutamide | null | N | CETUXIMAB | 101570676 |
| 20220243 | 20083892 | 1.76 | 51 | null | 2016-07-08 | 2016-07-15 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 100340220 |
| 20220248 | 20083893 | 1.62 | 114.1 | Neo-adjuvant (N) | 2019-04-02 | 2019-04-12 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100764645 |
| 20220249 | 20083894 | 1.6 | 50.9 | Neo-adjuvant (N) | 2020-02-06 | 2020-02-06 | Enzalutamide | 2 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101193402 |
| 20220258 | 20083895 | 1.71 | 65.9 | Palliative (P) | 2019-11-27 | 2019-12-13 | Capecitabine + Cisplatin + RT | 2 | N | CAPECITABINE + CISPLATIN + RT | 101480804 |
| 20220260 | 20083896 | 1.56 | 106 | Adjuvant (A) | 2018-06-12 | 2018-06-14 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101662255 |
| 20220261 | 20083897 | 1.56 | 76 | null | 2019-02-03 | 2019-02-11 | Enzalutamide | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101156959 |
| 20220269 | 20083898 | 1.66 | 80.5 | Palliative (P) | 2019-11-24 | 2019-12-12 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101471320 |
| 20220271 | 20083899 | 1.67 | 93.7 | Palliative (P) | 2020-04-13 | 2020-05-11 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101860077 |
| 20220281 | 20083900 | 0 | 92 | Curative (C) | 2017-01-28 | 2017-02-26 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 100260088 |
| 20220287 | 20083901 | 1.62 | 81.4 | Palliative (P) | 2017-02-06 | 2017-02-11 | Enzalutamide | 02 | N | CARBOPLATIN | 101331271 |
| 20220288 | 20083902 | 1.58 | 0 | Curative (C) | 2017-05-30 | 2017-05-31 | TRASTUZUMAB | 02 | null | CAPECITABINE + CISPLATIN + RT | 101788871 |
| 20220289 | 20083903 | 1.82 | 111 | Palliative (P) | 2018-12-08 | 2018-12-22 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100887922 |
| 20220290 | 20083904 | 1.65 | 66.8 | Palliative (P) | 2018-12-30 | 2019-02-02 | Trastuzumab 21 day loading dose | 02 | Y | TRASTUZUMAB | 100283204 |
| 20220292 | 20083905 | 1.67 | 67 | Palliative (P) | 2017-08-23 | 2017-08-23 | Enzalutamide | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100402414 |
| 20220295 | 20083906 | 1.77 | 74.2 | Curative (C) | 2020-07-03 | 2020-07-09 | Enzalutamide | 99 | Y | ATEZOLIZUMAB + BEVACIZUMAB | 101754354 |
| 20220298 | 20083907 | null | 80.6 | Neo-adjuvant (N) | 2019-04-13 | 2019-04-14 | Enzalutamide | null | null | CISPLATIN | 101706396 |
| 20220299 | 20083908 | 1.77 | 88.9 | null | 2019-03-27 | 2019-04-08 | Enzalutamide | 2 | null | CARBOPLATIN + GEMCITABINE | 100788704 |
| 20220302 | 20083909 | 1.57 | 74.4 | Neo-adjuvant (N) | null | 2019-03-09 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101128884 |
| 20220305 | 20083910 | 1.59 | 80.2 | Curative (C) | 2021-03-28 | 2021-04-24 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101279192 |
| 20220309 | 20083911 | 1.87 | 91.2 | Palliative (P) | null | 2019-08-04 | Mitomycin Intravesical | 02 | Y | MITOMYCIN INTRAVESICULAR | 100332141 |
| 20220312 | 20083912 | 1.66 | 63.6 | Palliative (P) | 2022-02-18 | 2022-02-18 | Enzalutamide | 02 | N | TRASTUZUMAB | 101030137 |
| 20220319 | 20083914 | 1.6 | 101.5 | null | 2018-02-16 | 2018-02-18 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 100230413 |
| 20220322 | 20083915 | 1.6 | 58 | Palliative (P) | 2021-06-01 | 2021-06-10 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100573254 |